Lifecore Biomedical Inc (LFCR)
5.115
+0.22
(+4.60%)
USD |
NASDAQ |
Jun 20, 16:00
5.10
-0.02
(-0.29%)
After-Hours: 20:00
Lifecore Biomedical Revenue (Annual): 103.27M for May 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| May 31, 2023 | 103.27M |
| May 31, 2022 | 111.27M |
| May 31, 2021 | 100.87M |
| May 31, 2020 | 160.07M |
| May 31, 2019 | 557.56M |
| May 31, 2018 | 524.23M |
| May 31, 2017 | 469.78M |
| May 31, 2016 | 476.92M |
| May 31, 2015 | 539.26M |
| May 31, 2014 | 476.81M |
| May 31, 2013 | 441.71M |
| May 31, 2012 | 317.55M |
| May 31, 2011 | 276.73M |
| May 31, 2010 | 238.22M |
| Date | Value |
|---|---|
| May 31, 2009 | 235.94M |
| May 31, 2008 | 238.53M |
| May 31, 2007 | 210.50M |
| May 31, 2006 | 231.95M |
| May 31, 2005 | 205.23M |
| May 31, 2004 | 192.09M |
| May 31, 2003 | 112.26M |
| October 31, 2002 | 183.16M |
| October 31, 2001 | 190.88M |
| October 31, 2000 | 197.16M |
| October 31, 1999 | 21.45M |
| October 31, 1998 | 33.50M |
| October 31, 1997 | 9.50M |
| October 31, 1996 | 2.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
100.87M
Minimum
2021
160.07M
Maximum
2020
118.87M
Average
107.27M
Median
Revenue (Annual) Benchmarks
| Aquestive Therapeutics Inc | 50.58M |
| SELLAS Life Sciences Group Inc | -- |
| ADMA Biologics Inc | 258.22M |
| Relmada Therapeutics Inc | -- |
| Jaguar Health Inc | 9.761M |